According to our experience, both PD-1 and PD-L1 immunohistochemical expression are associated with well-recognized histopathologic parameters of tumor aggressiveness and PD-L1 is also an independent marker of prognosis in our series, both on the tumor center and invasive fronts. Here, CD274 is linked to neoplasm.